Login to your account

Username *
Password *
Remember Me
RCT: Among children between the ages of 6 and 11 years with uncontrolled moderate-to-severe asthma, add-on Dupilumab reduced exacerbations and improved lung function.

RCT: Among children between the ages of 6 and 11 years with uncontrolled moderate-to-severe asthma, add-on Dupilumab reduced exacerbations and improved lung function.

Bibliographie
9 décembre 2021
Soyez le premier à commenter!

Dupilumab in Children with Uncontrolled Moderate-to-Severe Asthma – New England Journal of Medicine Commentary: International study supports dupilumab for treatment of moderate-to-severe asthma in children – Vanderbilt University Medical Center  

The post RCT: Among children between the ages of 6 and 11 years with uncontrolled moderate-to-severe asthma, add-on Dupilumab reduced exacerbations and improved lung function. appeared first on Links Medicus.

Lu 569 fois
Évaluer cet élément
(0 Votes)
Plus dans cette catégorie : « Multiple early studies find notable Omicron vaccine evasion. New Zealand to ban smoking for next generation in bid to outlaw habit by 2025 – “New legislation means the legal smoking age will increase every year, to create a smoke-free generation of New Zealanders”. »

About Author

Zouhair Souissi

Dernier de Zouhair Souissi

Laissez un commentaire

Assurez-vous d'entrer toutes les informations requises, indiquées par un astérisque (*). Le code HTML n'est pas autorisé.

Retour en haut

Search